Runtian Wang
Overview
Explore the profile of Runtian Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
237
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
He Z, Wang R, Wang C, Liao L
ACS Appl Mater Interfaces
. 2025 Feb;
17(9):14109-14118.
PMID: 39988801
Constructing multimetallic alloy heterostructures with the desired interface and phase separation is a promising method to optimize the electrochemical properties of noble metal nanomaterials. Nevertheless, tailoring the elemental distribution and...
2.
Xu J, Wang R, Guan X
Sci China Life Sci
. 2024 Oct;
68(1):294-296.
PMID: 39432206
No abstract available.
3.
Gao F, Wu Y, Wang R, Yao Y, Liu Y, Fan L, et al.
Acta Pharm Sin B
. 2024 Jun;
14(6):2685-2697.
PMID: 38828153
Targeting androgen receptor (AR) has shown great therapeutic potential in triple-negative breast cancer (TNBC), yet its efficacy remains unsatisfactory. Here, we aimed to identify promising targeted agents that synergize with...
4.
Wang R, Li G, Gao F, Xu F, Li X, Zhang J, et al.
Sci China Life Sci
. 2023 Dec;
67(4):698-710.
PMID: 38151609
Triple-negative breast cancer (TNBC) is the most challenging breast cancer subtype because of its aggressive behavior and limited therapeutic targets. c-Myc is hyperactivated in the majority of TNBC tissues, however,...
5.
Hu Q, Wang R, Zhang J, Xue Q, Ding B
Cancer Immunol Immunother
. 2023 Nov;
72(12):4293-4308.
PMID: 37907644
Tumor microenvironment (TME) cells orchestrate an immunosuppressive milieu that supports cancer cell proliferation. Tumor-associated neutrophils (TANs) have gained attention as inflammation biomarkers. However, the role of heterogeneous TAN populations in...
6.
Wang R, Hu Q, Wu Y, Guan N, Han X, Guan X
Biochim Biophys Acta Rev Cancer
. 2023 Aug;
1878(5):188962.
PMID: 37541532
Reprogramming of the tumor microenvironment (TME) is a hallmark of cancer. Metabolic reprogramming is a vital approach to sustaining the energy supply in the TME. This alteration exists in both...
7.
Wang R, Xu K, Chen Q, Hu Q, Zhang J, Guan X
J Transl Med
. 2023 Jun;
21(1):409.
PMID: 37353799
Background: Intra-tumoral heterogeneity (ITH) is a distinguished hallmark of cancer, and cancer stem cells (CSCs) contribute to this malignant characteristic. Therefore, it is of great significance to investigate and even...
8.
Li X, Zhang Z, Gao F, Ma Y, Wei D, Lu Z, et al.
J Am Chem Soc
. 2023 Apr;
145(16):9334-9342.
PMID: 37068218
Triple-negative breast cancer (TNBC) is highly aggressive with a poor clinical prognosis and no targeted therapy. The c-Myc protein is a master transcription factor and a potential therapeutic target for...
9.
Li X, Tang L, Chen Q, Cheng X, Liu Y, Wang C, et al.
Chin Med J (Engl)
. 2022 Dec;
135(20):2436-2445.
PMID: 36583862
Background: Cancer immunotherapy has emerged as a promising strategy against triple-negative breast cancer (TNBC). One of the immunosuppressive pathways involves programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1),...
10.
Hu Q, Wu G, Wang R, Ma H, Zhang Z, Xue Q
Front Immunol
. 2022 Nov;
13:1007812.
PMID: 36439090
Lung cancer is a disease with remarkable heterogeneity. A deep understanding of the tumor microenvironment (TME) offers potential therapeutic strategies against this malignant disease. More and more attention has been...